Wenling Dong serves as Head of Process Development Viral Vector at Lonza Specialized Modalities based in Houston. Leveraging over 25 years of experience in research, process development, and GMP manucturing, she leads a high-performing team to develop and tech transfer manufacturing processes for various viral vectors, focusing on product quality, safety, and efficacy. Prior to Lonza, she held roles as a bioprocess engineer at various healthcare companies, including Baxter, GSK, and Teva. Wenling holds a Masters of Science in Chemical and Biochemical Engineering from the University of Maryland Baltimore County, a Masters of Science in Applied Chemistry from Shanghai Jiao Tong University and Bachelor of Science in Chemical Engineering from East China University of Science and Technology.